Cochlear

Australian bionic ear manufacturer, Cochlear (ASX:COH) has announced a 68 percent fall in profit. The company's profit directly impacted from a product recall which lost the company 5 percent market share and a write down of $101.3 million.

Key Reporting Figures for Cochlear

• Revenue $779 million – down 4 percent for the year to June 30
• 23,087 implant unit sales, down 6 percent
• Net Profit after tax - $56.8 million for 2012

Cochlear (ASX:COH) shares crashed anew after rival Advanced Bionics (AB) made a comeback in the US market. Days after the biotech company recalled its Nucleus hearing implants, shares dropped over 15 percent to $51.01 before closing at $51.30, down 14.64 percent.

Hearing device company Cochlear (COH) saw its shares plummet yesterday after it declared a global recall of its Nucleus CI500 line due to a spike in product failure rates. Shares dropped over 20 percent to $57.50 as terrified investors sold out en masse.

The CI500 series accounts for about 70 percent of Cochlear sales and pulling it off the market cost the company more than $800 million in stock value.

ComputerShare

Share registry services provider Computershare Ltd's (ASX:CPU) full year profit fell by 10.4 percent while net profit dropped to $264.09 million for the 12 months to June 30 from $294.76 million last year. Revenue was flat from the previous year at $1.604 billion. ComputerShare declared final dividend of 14 cents per share, 60 per cent franked, unchanged from last year.

Dominos

Hearing implant systems manufacturer, Cochlear (ASX:COH) has announced a 19 percent increase in net profit at $130.5 million. The company has also announced a final dividend, which is 60 percent franked at $1.05.

• Net Profit after Tax (NPAT) of $155.2 million, up 19%.
• Successful launch of new cochlear implant system Cochlear™ Nucleus® 5 with second half CI unit sales up 20% and full year up 13% to 21,023 units

Aristocrat Leisure (ALL), a gaming company that develops gaming machines, software systems and other related equipment and runs business in Americas, Asia Pacific and Europe was the number one winning company of the 12th week in ASX100 with a gain of 7.3 percent or 32 cents to its stock price closing the week at $4.65 (market capitalisation $2480.2 million).

Cochlear (COH), an Australia based manufacturer and supplier of implantable hearing solutions have seen its shares to go up significantly mainly due to the speculation that the company is going for a $2.8 billion worth of bid for the hearing aid division of Siemens. Cochlear gained close to 2 percent to its stock price and was closed at $1.18 on Monday.

Despite the considerable uncertainty in the worldwide economy, Australia based renowned hearing solution manufacturer and supplier Cochlear (COH) has forecasted a positive outlook for its business. According to the chairman of the company Tommie Bergman, Cochlear is currently standing in a strong position and is expected to boost its earnings through its newly launched products. Mr.